Inhibitory Effects of Novel Immucillin Analogues on \u3ci\u3eBorrelia burgdorferi\u3c/i\u3e Bgp Nucleosidase by Guerrero, Christian et al.
Boise State University
ScholarWorks
IDeA Network for Biomedical Research Excellence (INBRE)
7-1-2012
Inhibitory Effects of Novel Immucillin Analogues
on Borrelia burgdorferi Bgp Nucleosidase
Christian Guerrero
Boise State University
Seth Eidemiller
Boise State University
Ken Cornell
Boise State University
  
Inhibitory Effects of Novel Immucillin Analogues on Borrelia burgdorferi Bgp Nucleosidase 
 
Christian Guerrero, Seth Eidemiller, and Ken Cornell, Ph.D. 
Department of Chemistry and Biochemistry, Boise State University 
 
 
This publication was made possible by the LSAMP Grant No. 
HRD 0901996  and the INBRE Program, NIH Grant Nos. P20 
RR016454 (National Center for Research Resources) and P20 
GM103408 (National Institute of General Medical Sciences) 
 
Acknowledgements  
• Recombinant Bgp was expressed and purified 
• Enzyme purity was confirmed by SDS-Polyacrylamide Gel 
Electrophoresis 
• Spectrophotometric analyses of Bgp activity were run using 
Cary 50 and 100 UV-Visible Spectrophotometers 
• Using Beer’s Law (A=clε), ε = 1.6mM-1cm-1 determined 
concentration of nucleosidase substrate in assay 
• Initial and delayed onset velocities (V0, V0’, V*) were 
calculated with varying concentrations of inhibitor 
• Using IgorPro, inhibition constants (Ki) were calculated by 
fitting data to the equation for competitive inhibition:  
V0’/ V0 = (Km + [S])/{(Km+[S]+Km[I]/Ki)}  
Methods 
     The pathogenic spirochaete Borrelia burgdorferi causes 
Lyme disease and is transmitted by deer ticks when they feed. 
Lyme disease is multisystemic—it adversely affects the heart, 
joints, and skin. Recent studies demonstrate that B. burgdorferi 
possesses three methylthioadenosine/S- 
adenosylhomocysteine (MTA/SAH) nucleosidases essential for 
the catabolic breakdown of both MTA and SAH. Both MTA and 
SAH are by-products of major pathways involving S-
adenosylmethionine (SAM) and are kept at low micromolar 
concentrations due to their inhibitory activity.  
 This project examined the effect of transition state 
inhibitors on the surface binding Borrelia glycosaminoglycan-
binding protein (Bgp) nucleosidase using recombinant Bgp and 
whole-cell B. burgdorferi activity assays. The transition state 
analogues are potent inhibitors of Bgp activity with Ki values 
ranging from 6pM-6nM. Bgp on the surface of live B. 
burgdorferi was also inhibited by treatment with low nanomolar 
concentrations of transition state analogues. 
Introduction 
Immucillin transition state analogues will be potent inhibitors of 
Bgp nucleosidase and antibiotics to treat Lyme disease. 
Hypothesis 
• Bgp is an active MTA nucleosidase found on the surface 
of B. burgdorferi 
• Immucillin analogues were potent inhibitors of 
recombinant Bgp with subnanomolar to low nanomolar Ki 
values 
• Bgp was readily inhibited in whole cell assays using low 
nanomolar concentrations of Immucillin analogues 
Results 
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The transition state analogues inhibit Bgp and live B. 
burgdorferi whole cells. Further studies can test inhibitors 
against  other MTA/SAH nucleosidases and lead to the 
development of new drugs that combat Lyme disease. 
Conclusion 
The Methionine Salvage Pathway 
Figure 2 Biological pathway present in B. burgdorferi and target for drug testing 
  Summary of Analogue Inhibition Constants  
Methylthio-Immucillin A 
(MT-ImmA) 
Ki = 6.43 nM 
Ki
* = 0.49 nM 
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Butylthio-DADMe -ImmA 
(BT-DADMe) 
Ki = 0.84 ± 0.092 nM 
Ki
*
 = 0.066 ± 0.0099 nM 
Methylthio-DADMe-ImmA  
(MT-DADMe) 
Ki = 6.88 nM 
Ki
*
 = 0.69 nM 
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Figure 5 Illustrations of inhibitors and corresponding inhibition curves (both 
early onset, V0’/V0 and delayed onset, V*/V0) 
Enzyme Inhibition Assay  
Figure 3 Spectrophotometric analysis (λ275) of Bgp hydrolysis of MTA in the 
presence of varying concentrations (0-1000nM) of MT-ImmA analogue 
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Live Whole Cell Assay 
Figure 4 Nucleosidase activity assay (λ275) of live B. burgdorferi  whole cells 
with varying concentrations (0-1000nM) of MT-ImmA analogue 
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Breakdown of Nucleosidase Substrate 
Figure 1 Catalysis of MTA to methylthioribose (MTR) and adenine (Ade) 
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